Callaly company

Callaly®'s first major innovation is a new type of tampon that is leak-proof and organic: the Tampliner®. The gynaecologist-invented Tampliner® allows for hygienic insertion while eliminating the need for hard plastic applicators. The globally patented Tampliner® is initially sold online through a customisable subscription, manufactured to medical-grade standards in Britain. Callaly is a B Corp, and is committed to achieving higher standards of social and environmental performance, accountability and transparency.
Technology: NeuroTech
Industry: Consumer Goods, Health Care
Headquarters: United Kingdom
Founded Date: 2014-09-02
Employees Number: 11-50
Funding Status: Seed
Investors Number: 1
Total Funding: £9.6M
Estimated Revenue: Less than $1M
Last Funding Type: Equity Crowdfunding

Visit Website
Register and Claim Ownership